Dr. Joosang Park Joins BioCell Technology to Further Research of Branded Ingredients
NEWPORT BEACH, CA -- OCTOBER 19, 2009 – BIOCELL TECHNOLOGY LLC – BioCell Technology, LLC, announced today the appointment of Joosang Park, PhD (Stanford University), MBA (Cornell University), as Vice President of Scientific Affairs. Dr. Park will be responsible for all R&D activities relating to the Company’s various patented and branded nutraceutical ingredients, including BioCell Collagen II® and i-Sabi®.
NEWPORT BEACH, Ca., February 2, 2004– BioCell Technology LLC, the exclusive suppliers of the Patented BioCell Collagen II® ingredient, released results from a double blind clinical study proving that the naturally occurring Hyaluronic Acid (HA) in the BioCell Collagen II® product has significant peak absorption and steady state bioavailability in normal volunteer subjects. Dr.
CLINICAL TRIAL SHOWS BIOCELL COLLAGEN II REDUCES WRINKLES AND IMPROVES HYDRATION
June 23, 2011, Newport Beach CA — BioCell Technology LLC announces the completion of the first human skin study of BioCell Collagen II® in women who have undergone natural and UV‐intensified aging processes. In broad brushstrokes, this study has demonstrated the safety and significant efficacy of BioCell Collagen II® in improving a variety of aging‐associated facial effects measured both qualitatively and quantitatively.
